Inzpera Healthsciences Profile
Key Indicators
- Authorised Capital ₹ 45.41 Cr
as on 08-12-2024
- Paid Up Capital ₹ 43.41 Cr
as on 08-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 08-12-2024
- Revenue 152.14%
(FY 2022)
- Profit -52.69%
(FY 2022)
- Ebitda -49.52%
(FY 2022)
- Net Worth -41.38%
(FY 2022)
- Total Assets 47.81%
(FY 2022)
About Inzpera Healthsciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 45.41 Cr and a paid-up capital of Rs 43.41 Cr.
The company currently has active open charges totaling ₹10.00 Cr.
The Key Managerial Personnel (KMP) at Inzpera Healthsciences Limited India are Rajesh Ramadurai as CFO and Mitesh Shah as Company Secretary. Narasimhan Kaushik, Kanwar Jamwal, Collur Natraj, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PLC282701
- Company No.
282701
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2016
- Date of AGM
27 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Inzpera Healthsciences Limited offer?
Inzpera Healthsciences Limited offers a wide range of products and services, including Health Conditions, Stomach Care, Respiratory Care.
Who are the key members and board of directors at Inzpera Healthsciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narasimhan Kaushik  | Managing Director | 22-Jun-2016 | Current |
| Rajesh Ramadurai | CFO | 08-Dec-2016 | Current |
| Mitesh Shah | Company Secretary | 06-Sep-2018 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Collur Natraj | Director | 26-Aug-2021 | Current |
| Adil Ahmad | Director | 24-May-2017 | Current |
| Kanwar Jamwal | Director | 22-Jun-2016 | Current |
| Rajesh Ramadurai | Whole-Time Director and Cfo | 08-Dec-2016 | Current |
Financial Performance of Inzpera Healthsciences.
Inzpera Healthsciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 152.14% increase. The company also saw a substantial fall in profitability, with a 52.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inzpera Healthsciences?
In 2022, Inzpera Healthsciences had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹10.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2020 | Others | ₹10.00 Cr | Open |
How Many Employees Work at Inzpera Healthsciences?
Inzpera Healthsciences has a workforce of 144 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inzpera Healthsciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inzpera Healthsciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
